JAZZ

Jazz Pharmaceuticals (JAZZ)

About Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$170.24

Daily low

$167.53

Price at open

$168.61

52 Week High

$182.99

52 Week Low

$95.49

Market cap

10.3B

Dividend yield

0.00%

Volume

981,593

Avg. volume

1.3M

P/E ratio

-27.93

Jazz Pharmaceuticals News